JEVRIQ Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for JEVRIQ with the United States Patent and Trademark Office. The USPTO has given the JEVRIQ trademark a serial number of 97093033. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, January 28, 2025. This trademark is owned by Bausch + Lomb Ireland Limited. The JEVRIQ trademark is filed in the Pharmaceutical Products category with the following description:

ophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders
jevriq

General Information

Serial Number97093033
Word MarkJEVRIQ
Filing DateTuesday, October 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and Servicesophthalmic pharmaceutical substances and preparations for the treatment of ocular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBausch + Lomb Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 24
IE
Party NameBausch + Lomb Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 24
IE

Trademark Events

Event DateEvent Description
Friday, October 29, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022SUSPENSION LETTER WRITTEN
Wednesday, May 18, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, May 18, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 21, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 2 FILED
Wednesday, January 17, 2024SOU EXTENSION 2 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 11, 2024SOU TEAS EXTENSION RECEIVED
Sunday, August 11, 2024SOU EXTENSION 3 FILED
Tuesday, January 28, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2025SOU EXTENSION 4 FILED
Tuesday, January 28, 2025SOU EXTENSION 4 GRANTED
Wednesday, January 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 11, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 1 FILED
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED

Related Keywords

jevriq ocular diseases disorders treatment preparations pharmaceutical substances ophthalmic